NonExomics
Acton
About NonExomics
NonExomics integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine learning approaches to predict structures of nonexomic proteins and identifies disease-specific nonexomic targets, allowing clients to find cures for rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Mar 2022)
- Website: nonexomics.com
- Phone: 6178162721
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nonexomics-103903 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.